Open access
Jul 2026
Targeting NAT10 suppresses TFH responses and alleviates allergic asthma via an ac4C-TOX2 axis
This work elucidates a central epitranscriptomic mechanism controlling T helper cell fate and humoral immunity, and nominates NAT10 as a potential therapeutic target for TFH-driven diseases.
Zhou-Li Cheng, Zihao Lin, Yilin Ren et al.
· bioRxiv · 0 citations